Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2023-04-03 00:00:00 ET · period of report 2023-03-30 · accession 0001209191-23-022432 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-04-03 | 2023-03-30+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +4,400 | 530.0K | +0.8% | +$2,684 |
| DM | 2023-04-03 | 2023-03-30+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.08 | -4,400 | 528.0K | -0.8% | -$70.7K |
| DM | 2023-04-03 | 2023-03-30+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.00 | -4,400 | 231.8K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-30 | M | A | 2,000 | $0.61 | 529,981 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-30 | S | D | 2,000 | $16.01 | 527,981 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-31 | M | A | 400 | $0.61 | 528,381 | D | — | — | |
| 4 | Common | Common Stock | 2023-03-31 | S | D | 400 | $16.00 | 527,981 | D | — | — | |
| 5 | Common | Common Stock | 2023-04-03 | M | A | 2,000 | $0.61 | 529,981 | D | — | — | |
| 6 | Common | Common Stock | 2023-04-03 | S | D | 2,000 | $16.16 | 527,981 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-04-03 | M | D | 2,000 | $0.00 | 229,421 | D | $0.61 · — to 2031-03-09 | 2,000 Common Stock | (F2) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-03-31 | M | D | 400 | $0.00 | 231,421 | D | $0.61 · — to 2031-03-09 | 400 Common Stock | (F2) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-03-30 | M | D | 2,000 | $0.00 | 231,821 | D | $0.61 · — to 2031-03-09 | 2,000 Common Stock | (F2) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |